Compare Live Nation Entertainment, Inc. (LYV) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Nuwellis Inc — how do they compare? Live Nation Entertainment, Inc. trades at $183.14 (market cap $42.71B), while Nuwellis Inc trades at $1.5 (market cap $542.80K). The key difference: Live Nation Entertainment, Inc. is far larger — about 78684.6× Nuwellis Inc's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| LYV | NUWE | |
|---|---|---|
Market Cap | $42.71B | $542.80K |
Sector | Industrials | Technology |
52-Week High | $186.59 | $220.50 |
52-Week Low | $125.61 | $1.42 |
Enterprise Value | $44.92B | -$1.27M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
